Article Type
Original Study
Abstract
Objective The purpose of this study was to assess the efficacy and safety of intravenous 3% hypertonic saline (HTS) compared with mannitol 20% for lowering intraocular pressure (IOP) in patients with glaucoma. Patients and methods A total of 30 patients between age 35 and 60 years with American Society of Anesthesiologist status I–III with glaucoma (IOP=30 mmHg) were enrolled in a double-blind comparative study. Patients were randomized to one of two groups: group GH (n=15), where patients received HTS, and group GM (n=15), where patients received mannitol 20%. Results Regarding demographic data, no statistically significant difference was observed between the two groups. There was a statistically significant decrease in mean arterial pressure in GH when compared with GM. There was a statistically significant increase in Na level in GH in comparison with GM. There was statistically significant decrease in K level in GH more than in GH. Regarding pH, there was no statistically significant between the two groups. Conclusion Intravenous infusion of HTS 3% is effective in decrease IOP in patients with glaucoma. It is considered a good alternative to mannitol for this purpose.
Keywords
Glaucoma, hypertonic saline, mannitol
Recommended Citation
Ibrham, Alaa A.; H. Mhmoud, Ashraf A.; Mohamed, Mohmed H.; and E. Elhakeem, Wael A.
(2020)
"Efficacy and safety of intravenous 3% hypertonic saline compared to mannitol 20% for lowering intraocular pressure in patients with glaucoma: A prospective randomized double-blind study,"
Journal of Medicine in Scientific Research: Vol. 3:
Iss.
2, Article 5.
DOI: https://doi.org/10.4103/JMISR.JMISR_82_19